Baxter International IncNYSE:BAX
Symbol Lookup
Refresh
Recent News»
0 New Today| Company | Market Cap | P/E Ratio (TTM) | EPS Growth (5yr) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Teva Pharmaceutical Industries Ltd TEVA | 37.8B | 17.9x | -0.98% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Allergan Inc AGN | 29.2B | 26.3x | +17.78% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Abbott Laboratories ABT | 58.9B | 77.3x | -30.92% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Bristol-Myers Squibb Co BMY | 71.9B | 49.9x | +12.31% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Valeant Pharmaceuticals International Inc VRX | 24.0B | -- | -- | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Data delayed 15 minutes. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Company Information
Baxter International Inc. (Baxter) is a global, diversified healthcare company. Baxter, through its subsidiaries, develops, manufactures and markets products that save and sustain the lives of people with hemophilia, immune disorders, infectious diseases, kidney disease, trauma, and other chronic and acute medical conditions. The Company operated in two segments: BioScience and Medication Delivery. It is engaged in the medical devices, pharmaceuticals and biotechnology to create products that advance patient care worldwide. These products are used by hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors' offices, clinical and medical research laboratories, and by patients at home under physician supervision. In February 2012, it acquired Synovis Life Technologies, Inc. In November 2011, it acquired Baxa Corporation. In April 2012, it purchased SIGMA International General Medical Apparatus, LLC.
| Headquarters | One Baxter Parkway DEERFIELD, IL, United States 60015-4625 |
|---|---|
| Phone | 800-422-9837 |
| Fax | 800-568-5020 |
EXECUTIVE OFFICERS
| Chairman of the Board, Chief Executive Officer | Robert Parkinson |
|---|---|
| Chief Financial Officer, Corporate Vice President | Robert Hombach |
| Corporate Vice President, General Counsel | David Scharf |
| Corporate Vice President, Controller | Sebastian Bufalino |
| Corporate Vice President - Human Resources | Jeanne Mason |
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
With TD Waterhouse, you have access to the industry's leading selection of independent research reports from providers such as TDSI, TD Securities, S&P, INK and Argus.
Open a New Account, or Login if you're a client.
(GAAP)*
| Market Cap | $39.5B | Beta | 0.51 |
|---|---|---|---|
| Revenue (TTM) | $14.3B | EPS | $4.15 |
| Shares Out. | 542.0M | Book Value | $12.70 |
| Dividend Yield | 2.68% | P/E | 17.6x |
| Annual Dividend Rate | $1.96 | Price/Sales (TTM) | 2.8 |
| Ex-Div Date | 6/5/13 | P/Cash Flow (TTM) | 12.9x |
| Pay Date | 6/5/13 | Operating Margin | 19.98% |
*GAAP = prior to non-GAAP analyst adjusted earnings.
(Non-GAAP)*
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
